LIPOSUC
LIVE

Serial Number

79149816

Owner

BIOFAR

Attorney

Amy Wright

Filing Date

Mar 3, 2014

Add to watchlist:

No watchlists yet
View on USPTO

LIPOSUC Trademark

Serial Number: 79149816 • Registration: 4766385

LIPOSUC is a trademark filed by BIOFAR on March 3, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 32 (Light Beverages). The application is currently registered and active.

Owner Contact Info

BIOFAR (7 trademarks)

6, rue des Marguerites
F-92000 NANTERRE , FR

Entity Type: 99

Trademark Details

Filing Date

March 3, 2014

Registration Date

July 7, 2015

Published for Opposition

April 21, 2015

Cancellation Date

January 21, 2022

Goods & Services

Pharmaceutical products for enhancing energy production; anti-viral pharmaceutical preparations; medicines for human medicine, namely, for enhancing energy production; pharmaceutical preparations against flu; pastilles for pharmaceutical or medical purposes, namely, fumigating pastilles as disinfectants; cough syrup; pharmaceutical products and parapharmaceutical products for enhancing energy production which may contain proteins, carbohydrates, lipids and/or fibers, or micronutrients such as vitamins and/or minerals, amino acids and/or fatty acids, in the form of individual doses and food supplements for medical or paramedical use which may contain proteins, carbohydrates, lipids and/or fibers, or micronutrients such as vitamins and/or minerals, amino acids and/or fatty acids, in the form of individual doses; pharmaceutical products for enhancing energy production made with plants, plant extracts and/or vegetable extracts in effervescent or other forms; parapharmaceutical preparations, namely, plant-based food supplements, plant extracts for medical and pharmaceutical purposes and/or vegetable extracts in the nature of nutritional food additives for medical purposes in the nature of natural food extracts derived from fish, meat, vegetables, in effervescent or other forms; parapharmaceutical products for enhancing energy production used for medical purposes, based on plants, plant extracts, and/or vegetable extracts in effervescent or other forms; pharmaceutical and parapharmaceutical preparations for enhancing energy production containing minerals and/or vitamins in effervescent or other forms; minerals and vitamins preparations for medical use in effervescent or other forms; pharmaceutical products for phytotherapy for enhancing energy production; nutritional supplements for the nutrient intake in a normal diet; dietetic substances adapted for medical use, namely, dietetic sugar for medical use, dietetic foods in the nature of pasta adapted for medical use; nutritional supplements for medical or pharmaceutical use ready for human consumption based on food ingredients of plant and/or mineral origin; strengthening food substances, namely, food supplements, vitamins for medical purposes; medicinal herbs; herbal teas for medicinal purposes; dietetic sugar for medical use; dietetic beverages for medical use, namely, herbal teas for medicinal purposes, dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; medicated confectionery; nutritional supplements for paramedical use as additions to the nutrient intake in a normal diet, all for paramedical use; dietetic substances, namely, dietetic sugar for medical use, dietetic foods in the nature of pasta adapted for medical use, nutritional supplements for paramedical use prepared for human consumption based on foodstuffs of vegetable and/or mineral origin, for strengthening, and for paramedical use which may contain proteins, carbohydrates, lipids and/or fibers, or micronutrients such as vitamins and/or minerals, amino acids and/or fatty acids, in the form of individual doses; dietetic beverages for medical use, namely, herbal teas for medicinal purposes, dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; dietetic or dietary goods, namely, herbal teas for medicinal purposes, dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes, meal replacements, namely, chocolate-based meal replacement bars for medical purposes, nutritional and herbal supplements

Meat, fish, poultry and game; meat extracts, sausages; deep-frozen, preserved, dried and/or cooked fruit and vegetables; prepared vegetables; jellies, jams, compotes, eggs, milk and dairy products excluding ice cream, ice milk and frozen yogurt; edible oils and fats; fats for food; butter; prepared and cooked dishes made primarily with meat, fish, seafood, fruit and vegetables; canned fruit, vegetables, fish or meat; vegetable juices for cooking; fruit and vegetable salads; frozen, prepared or packaged meals made primarily from fruits, vegetables, poultry, game, meat extracts, sausages, fish or meat; soups; bouillon; tinned fruits and tinned vegetables; pickles; fruit-based desserts, namely, dried fruit, fruit salad; cheeses; milk beverages, milk predominating; snack foods based on meat, fish, poultry, game, meat extracts, sausages, fruit or vegetables

Beers; mineral and aerated waters and other non-alcoholic beverages, namely, fruit juices; fruit beverages and fruit juices; syrups for making beverages, excluding those based on coffee, tea or cocoa, and milk beverages; and other preparations, namely, concentrates, powders, for making beverages, fruits drinks excluding those based on coffee, tea or cocoa, and milk beverages; isotonic beverages; lemonades; fruit nectars; soda water; non-alcoholic aperitifs; energy drinks; essences for making beverages, namely, non-alcoholic beverages, soft drinks; vegetable juices; preparations for making beverages, namely, fruit drinks

Filing History

INTERNATIONAL REGISTRATION RENEWED
Mar 29, 2024 RNWL
FINAL DECISION TRANSACTION PROCESSED BY IB
May 23, 2023 FINT
GENERIC MADRID TRANSACTION SENT TO IB
Apr 10, 2023 XXSS
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 10, 2023 INNA
GENERIC MADRID TRANSACTION CREATED
Apr 10, 2023 XXCR
REFUSAL PROCESSED BY IB
Dec 11, 2022 RFNT
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 21, 2022 INTR
CANCELLED SECTION 71
Jan 21, 2022 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 7, 2020 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 4, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 5, 2015 FICS
FINAL DISPOSITION PROCESSED
Nov 5, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 7, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 7, 2015 R.PR
PUBLISHED FOR OPPOSITION
Apr 21, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Apr 17, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 1, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 1, 2015 OP2R
NOTICE OF PUBLICATION
Apr 1, 2015 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 13, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2015 CRFA
ASSIGNED TO LIE
Feb 16, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2015 TROA
REFUSAL PROCESSED BY IB
Sep 5, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 8, 2014 RFCS
REFUSAL PROCESSED BY MPU
Aug 8, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 8, 2014 RFCR
NON-FINAL ACTION WRITTEN
Aug 7, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 5, 2014 MAFR
ASSIGNED TO EXAMINER
Aug 1, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 1, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 31, 2014 REPR